Skip to main content

ANALOGOS NO PEPTIDICOS DEL PEPTIDO R3 COMO HERRAMIENTA PARA INHIBIR EL CRECIMIENTO TUMORAL DEL TNBC MEDIANTE BLOQUEO DE LA ANGIOGENESIS Y DEL RECLUTAMIENTO DE NEUTROFILOS

SAF2015-66365-R

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2015
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Dirección General de Investigación Científica y Técnica
Beneficiary centre FUNDACIO INSTITUT D INVESTIGACIO BIOMEDICA DE BELLVITGE (IDIBELL)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Cis-trans proline isomers in the catalytic domain of calcineurin

  • Teixeira, João M. C.
  • Guasch, Alicia
  • Biçer, Atilla
  • Aranguren-Ibáñez, Álvaro
  • Chashmniam, Saeed
  • Paniagua, Juan Carlos
  • Pérez‐Riba, Mercè
  • Fita, Ignacio
  • Pons, Miquel
Calcineurin is an essential calcium‐activated serine/threonine phosphatase. The six NMR‐observable methionine methyl groups in the catalytic domain of human calcineurin Aα (CNA) were assigned and used as reporters of the presence of potential cis‐trans isomers in solution. Proline 84 is found in the cis conformation in most calcineurin X‐ray structures, and proline 309, which is part of a highly conserved motif in phosphoprotein phosphatases, was modeled with a cis peptide bond in one of the two molecules present in the asymmetric unit of CNA. We mutated each of the two prolines to alanine to force the trans conformation. Solution NMR shows that the P84A CNA mutant exists in two forms, compatible with cis‐trans isomers, while the P309A mutant is predominantly in the trans conformation., The work was partially supported by funds from the Spanish Ministry of Economy, Industry, and Competitiveness (MINECO) (BIO2016‐78006R, to MP; BFU2015‐71092‐P to IF; SAF2015‐66365 and RTC‐2015‐3386‐1, to MP‐R; Units of Excellence María de Maeztu awards to IF (MDM‐2014‐0435) and to JCP (MDM‐2017–076). Some of the funds were cofinanced with the European Fund for Regional Development (FEDER). We acknowledge additional support from Generalitat de Catalunya (2014‐SGR‐541 and 2017‐SGR‐191). A.B. was funded by the RTC‐2015‐3381‐1 grant. S.C. was a recipient of a short‐term fellowship from the Iranian Government.